As you read this, corporate advisers are preparing strategic options for Life Healthcare, in the wake of 22% shareholder Mvelaphanda announcing last September that it was realising and unbundling its assets. One option, say market sources, is a listing on the JSE, as early as May. Another is that 21.9% shareholder Brimstone Investment might snap up Mvela’s stake, valued at around R1.6bn.
Life Healthcare Group is currently valued at around R7.4bn. Brimstone and Tokyo Sexwale’s Mvela were the leaders in a BEE consortium that acquired the group. Their mission is simply to boost the bottom line.
But who will rush to buy Life Healthcare Group shares after reading this?
Like to see more ?
Subscribe to our on-line edition !
For a mere R298.00 per year you get the convenience of our online version including:- Twelve monthly issues of Noseweek delivered to your browser
- A searchable archive
- Access to every back issue since 1993 !
- A downloadable PDF version
If it's just this article you are after, you can purchase it for R30.00 by clicking here.
Tempted ?
For a taste of what awaits you, you are welcome to browse Last month's issue for free !









Previous Issues